Market closed
Septerna Inc/$SEPN
Septerna shares are trading higher after announcing a $2.2 billion global collaboration and license deal with Novo Nordisk to develop oral small molecule medicines targeting obesity and other cardiometabolic diseases.
23 hours ago·Lightyear AI
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Septerna Inc
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Ticker
$SEPN
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
75
ISIN
US81734D1046
Website
Septerna Inc Metrics
BasicAdvanced
$452M
-
-$7.26
-
-
Price and volume
Market cap
$452M
52-week high
$11.36
52-week low
$4.66
Average daily volume
1.4M
Financial strength
Current ratio
27.771
Quick ratio
27.399
Long term debt to equity
5.624
Total debt to equity
6.065
Management effectiveness
Return on assets (TTM)
-17.20%
Return on equity (TTM)
-27.05%
Valuation
Price to revenue (TTM)
93.483
Price to book
1.07
Price to tangible book (TTM)
1.07
Price to free cash flow (TTM)
-1.444
Growth
Revenue change (TTM)
611.92%
Earnings per share change (TTM)
-2,612.87%
Septerna Inc News
AllArticlesVideos
Septerna stock pops on partnership with Novo Nordisk to develop obesity therapies
Proactive Investors·1 day ago
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs
Benzinga·1 day ago
Novo Nordisk and Septerna Collaborate on Oral Medicines for Obesity and Other Diseases
WSJ·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Septerna Inc stock?
Septerna Inc (SEPN) has a market cap of $452M as of May 15, 2025.
What is the P/E ratio for Septerna Inc stock?
The price to earnings (P/E) ratio for Septerna Inc (SEPN) stock is 0 as of May 15, 2025.
Does Septerna Inc stock pay dividends?
No, Septerna Inc (SEPN) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next Septerna Inc dividend payment date?
Septerna Inc (SEPN) stock does not pay dividends to its shareholders.
What is the beta indicator for Septerna Inc?
Septerna Inc (SEPN) does not currently have a Beta indicator.